Novel mutational and pathway signatures in relapsed/refractory colorectal cancer patients. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract does not include a full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback